Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Integrative Multi-Omics Reveals Differential Mechanisms of Four TCM Formulations in Treating Insomnia via Syndrome-Compound-Metabolite Association Networks

AI Summary
  • Integrative multi-omics shows GPW, WLC, BLMC, ZRASC act via heterogeneous, syndrome-associated microbiota remodeling, metabolic reprogramming, anti-inflammatory and anti-ferroptosis mechanisms.
  • All formulations suppressed Alistipes and reversed 39 serum metabolites enriched in glutathione metabolism and pentose phosphate pathway.
  • Hypothalamic transcriptomics and network analysis revealed distinct drug-specific signatures and a gradient of microbiota metabolite associations: WLC 158 GPW 393 BLMC 836 ZRASC 1,243.
Summarise with AI (MRCPsych/FRANZCP)

J Ethnopharmacol. 2026 Nov 6:122598. doi: 10.1016/j.jep.2026.122598. Online ahead of print.

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Guipi Pills (GPW), Wuling Capsule (WLC), Bailemian Capsule (BLMC), and Zaoren Anshen Capsule (ZRASC) are representative traditional Chinese medicine formulations for treating insomnia based on different syndromes of Heart-Spleen Deficiency, Heart-Kidney Disharmony, Liver Qi Stagnation with Yin Deficiency, and Heart Blood Deficiency, respectively. However, their molecular mechanisms remain unclear.

AIM OF THE STUDY: To elucidate the “same disease, different treatment” mechanisms of these four formulations against sleep deprivation-induced insomnia through an integrated multi-omics and network pharmacology strategy.

MATERIALS AND METHODS: Chemical constituents were characterized by UHPLC-Orbitrap-MS/MS. A meta-analysis evaluated clinical differences and syndrome consistency. Subsequently, A mouse model of sleep deprivation was established; behavioral tests and HE/Nissl staining were performed. On this basis, fecal 16S rRNA gene sequencing, serum metabolomics, and hypothalamic transcriptomics were integrated to construct a microbiota-metabolite network. Furthermore, network pharmacology and molecular docking predicted component-target interactions. Finally, key protein expression was validated by western blot.

RESULTS: UHPLC-Orbitrap-MS/MS identified 87, 56, 163, and 128 compounds from GPW, WLC, BLMC, and ZRASC, respectively. Meta-analysis (62 RCTs, 6,045 patients) showed WLC and BLMC reduced PSQI scores alone or in combination; ZRASC benefited only in combination, and GPW combination benefit was borderline. Syndrome-efficacy interactions were inconsistent. In mice, all formulations alleviated neuronal damage despite heterogeneous behavioral improvements. All four formulations suppressed Alistipes and commonly reversed 39 serum metabolites enriched in glutathione metabolism and pentose phosphate pathway. Each formulation showed syndrome-related metabolic regulation. Hypothalamic transcriptomics revealed commonly downregulated genes (S100a9, Gbp5, Fpr1, Tnfsf8) and distinct patterns: lipid metabolism-immune suppression (GPW), transcriptional-metabolic inhibition (WLC), prolactin signaling (BLMC), and PPAR-driven energy repair (ZRASC). In an exploratory analysis, the number of microbiota-metabolite association pairs increased from WLC (158) to GPW (393), BLMC (836), and ZRASC (1,243); this gradient is hypothesis-generating and warrants independent validation.Network pharmacology and molecular docking predicted potential formulation-specific and common inflammatory pathway targets. Finally, western blot showed all formulations downregulated iNOS and COX2; all except WLC upregulated SLC7A11, GPX4, FTH, and Bcl2 (P < 0.05).

CONCLUSION: In this study, these four formulations showed heterogeneous, syndrome-associated patterns across microbiota remodeling, metabolic reprogramming, anti-inflammation, and anti-ferroptosis, which may help generate hypotheses regarding the “same disease, different treatment” principle. The findings provide a mechanistic basis for clinical application and a methodological reference for TCM modernization.

PMID:42994575 | DOI:10.1016/j.jep.2026.122598

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD